Decraecker, Marie
Le Joncour, Sophie
Aurillac, Valérie
Sangnier, Maïté
Ducerf, Camille
Berroneau, Aude
Rouleau, Laetitia
Tougeron, David
Laplace, Christophe
Madau, Magali
Dumon, Camille
Perrier, Herve
Blanc, Jean-Frédéric
Article History
Received: 23 May 2024
Accepted: 13 November 2025
First Online: 28 November 2025
Declarations
:
: The study was conducted closely with international guidance including the Good Clinical Practices and the Declaration of Helsinki. According to French national laws, the study was approved by a national Ethics Committee (CPP Est III, IDRCB 2023-A01665-40) and Competent Authority (ANSM) has been informed (NCT06006728, Registration Date: August 23, 2023). All alive participants have been provided comprehensive information notice regarding the purpose of the study, possible risks and expected benefits of the study, and participant's rights (voluntary participation and freedom to decline participation in the trial).All alive participants provided a Consent to Participate declaration.
: Not applicable.
: The authors declare no competing interests.